3/13/2026 4:54:40 PM Iran-Linked Cyberattack: What U.S. Companies Need to Know Now By Aaron Tantleff Jennifer Urban Christopher Swift Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the...
3/12/2026 3:29:38 PM GLP‑1 Compliance: FDA Targets Telehealth Marketing in 30 New Warning Letters By Jessa Boubker Kyle Faget Nate Beaver On March 3, 2026, U.S. Food & Drug Administration (FDA) sent 30 warning letters to telehealth companies that market compounded GLP‑1...
3/9/2026 8:28:39 PM New Markets Tax Credit Financing: Subsidy for Health Care Facilities and Operations By Nick Kitzman Alan Kennard Enacted 25 years ago, the federal New Markets Tax Credit (NMTC) Program has become a powerful financing tool for health care...
3/9/2026 2:02:40 PM Targeted Healing Before Birth: Placenta-Derived Stem Cells in Prenatal Repair of Spinal Defects By Antoinette Konski Neural tube defects are among the most challenging congenital conditions in medicine, with a devastating burden on patients, families,...
3/4/2026 6:07:38 PM Health Care Compliance in 2026: What Compliance Leaders Need to Know By Judy Waltz Jana Kolarik PYA and Foley & Lardner hosted the 8th Annual “Let’s Talk Compliance” conference on January 22, 2026. Panelists included Foley attorneys...
2/26/2026 8:08:09 PM CMS’s New DMEPOS Enrollment Moratorium: What Suppliers Need to Know By Leah Richardson Adam Cooper Josh Skora On February 25, 2026, the Centers for Medicare & Medicaid Services (CMS) announced, among other actions, a six-month nationwide...
2/24/2026 9:52:11 PM Bridging AI and Clinical Reality: Lessons from the Mayo Clinic Platform in Precision Medicine By Antoinette Konski Artificial intelligence is no longer a peripheral tool in personalized medicine. AI is becoming a central driver of how diagnostics,...
2/24/2026 2:59:39 PM FDA Issues Draft Guidance on Using the “Plausible Mechanism” Framework to Develop Individualized Therapies for Rare Genetic Diseases By Antoinette Konski On February 23, 2026, the U.S. Food and Drug Administration (FDA) released its Draft Guidance for Industry, “Considerations for the Use...
2/18/2026 4:27:39 PM “The Great American Recovery Initiative”: What President Trump’s New Executive Order Means for Behavioral Health Providers By Frankie Camacho Alex Maulden Hannah Zaitlin On January 29, 2026, President Trump signed Executive Order 14379, titled: “Addressing Addiction Through the Great American Recovery...
2/10/2026 6:12:09 PM PBM Reform Cheat Sheet: Chart Comparing the Recent Rules for Group Plans By Nick Welle Hannah Demsien Iris Grossman Key Takeaways: Within a one-week period, there were two actions at the federal level to increase pharmacy benefits manager (PBM)...
2/9/2026 2:15:10 PM Medicare Advantage: New OIG Compliance Guidance Has Implications for Providers By Alex Maulden Judy Waltz Background On February 3, 2026, the U.S. Department of Health & Human Services, Office of Inspector General (OIG), published the...
2/4/2026 5:21:38 PM A New Humanized Fc Mouse Model to De-Risk and Scale Antibody Programs, and Enable Innovation By Oyvind Dahle A recent Science Immunology paper reports a humanized Fc receptor mouse model designed to reflect human immune biology relevant to...
2/2/2026 9:11:09 PM DOL Proposes Sweeping New Disclosure Rules for Pharmacy Benefit Managers By Nick Welle Hannah Demsien Iris Grossman Background On January 30, 2026, the Department of Labor’s (DOL) Employee Benefits Security Administration (EBSA) published proposed...
1/29/2026 4:00:39 PM Medicare Telehealth Flexibilities: Countdown to January 30, 2026 (and What Comes Next) By Marika Miller Key Takeaways The Medicare telehealth flexibilities are set to expire on January 30, 2026. Without Congressional action, Medicare...
1/27/2026 8:40:10 PM Digital Health Policy: FDA Relaxes Restrictions over Wearables and AI Decision Making Tools in Two New 2026 Guidances By Jessa Boubker Nate Beaver Monica Chmielewski Kyle Faget Bill Holtz David Rosen +3 more... Show less On January 6, 2026, the U.S. Food & Drug Administration (FDA) updated two guidance documents, General Wellness: Policy for Low Risk...
1/22/2026 9:22:09 PM Texas Governor Issues New Directive on Medicaid Fraud Enforcement: Five Things That Managed Care Organizations Should Do Now By Nanette Beaird David Cabrales John Sepehri Key Takeaways: Enhanced Scrutiny of MCO SIUs: All Medicaid Managed Care Organizations must demonstrate full compliance with Texas’ SIU...